46 That dedicated kidney outcomes study, involving over 3500 patients with both T2D and established chronic kidney disease, demonstrated that once-weekly subcutaneous semaglutide 1.0 mg significantly reduced the primary composite renal outcome (including kidney failure onset, a 50% persistent decline in estimated glomerular filtration rate (eGFR), or renal/cardiovascular death) compared with placebo
Our ShapeScale 3D body scanner captures your full body composition over time , so you can see exactly where the fat is going, celebrate wins, and stay motivated when the scale stalls
however, dose titration and monitoring remain individualized based on clinical response and tolerance
Eat a balanced diet: Encourage whole grains, lean proteins, fruits, vegetables, and healthy fats
There are reports that some people are finding that cocktails lose their appeal